Disclaimer

The trademark information displayed on this page is public information and is provided for informational purposes only. This information may be incomplete, inaccurate, or outdated, and IndiaFilings does not guarantee its accuracy. IndiaFilings is an independent platform and is not associated, affiliated, or connected with any trademark listed in this database. We do not represent or speak on behalf of any such trademark. If you are trying to contact a specific trademark, please use their official channels. IndiaFilings cannot assist with queries directed at other companies.

Aimtinib

Class 5Status: Registered
Application Number2599938
Trademark Status
Registered
Trademark Class5
Application Date2013-09-21
Proprietor Name(1) AIMCAD BIOTECH PVT LTDTrading As : Aimcad Biotech Pvt Ltd , B 32/16-D, Rashmi Nagar, LANKA VARANASI 221005 (UP)Body Incorporate
Appropriate OfficeDELHI
StateUTTAR PRADESH
Trademark TypeWORD
User Details15/01/2013
Agent NameDR S K MARWAH[7732]
Agent AddressH No 901, Sector 70 MOHALI 160071 (Punjab) Mobile: 9781360607
Goods And Services Details[CLASS : 5] Medicine for human purposePublication Details Published in Journal No. : 1783-0     Dated : 06/02/2017

Trademark Protection

Automate the monitoring of your trademark application and filing of response to Government Objection or Hearing.

₹9,899+ GST

What's included:

✓
Brand Guard ( 1 application 1 class)
✓
Appointment of Lawyer
✓
Objection
✓
Hearing
✓
Infringement support (1)
✓
Power of Attorney (POA)

Frequently asked questions

Common questions about Aimtinib.

What is the status of trademark application 2599938?
The current status of trademark application 2599938 for Aimtinib is Registered.
What is the trademark class of Aimtinib?
Aimtinib is registered under trademark class 5.
Who is the proprietor of Aimtinib?
The proprietor of Aimtinib is (1) AIMCAD BIOTECH PVT LTDTrading As : Aimcad Biotech Pvt Ltd , B 32/16-D, Rashmi Nagar, LANKA VARANASI 221005 (UP)Body Incorporate.
When was trademark application 2599938 filed?
Trademark application 2599938 for Aimtinib was filed on 2013-09-21.